MedPath

Joint Injections for Osteoarthritic Knee Pain

Phase 1
Completed
Conditions
Osteoarthritis
Interventions
Procedure: Dextrose Prolotherapy
Procedure: Saline Prolotherapy
Other: At-home physical therapy exercise group
Registration Number
NCT00085722
Lead Sponsor
University of Wisconsin, Madison
Brief Summary

The purpose of this study is to determine whether prolotherapy (PrT), a therapy based on injection of a sugar solution in and around the knee, can decrease pain and disability from knee osteoarthritis (OA).

Detailed Description

OA is a common, debilitating condition for which there is no cure and no known cause. Prolotherapy (PrT) is an injection-based therapy for chronic musculoskeletal pain in which an irritant solution is injected at painful ligaments and tendons to produce stronger connective tissue and decrease pain. Although limited studies suggest PrT is effective may be effective for low back pain, its use has not been rigorously studied in human clinical trials for osteoarthritis.

Participants in this study will be randomly assigned to receive one of three treatments: standard PrT, injections with a saline placebo, or a pamphlet with recommendations for home knee physical therapy. Injections will be given at Weeks 1, 5, and 9; injection group subjects will have the option to receive an additional 2 sets of injections. All participants will be assessed for a total of 1 year. A set of disease-specific and general quality-of-life questionnaires will be used to assess participants' outcomes . A randomized subset of participants (N=38)will receive magnetic resonance imaging (MRI)of the knee at baseline and 52 weeks. At study completion, participants who did not receive PrT will have the option to receive up to five sessions of PrT at no cost. Data will be collected for this group (minus MRI) and will be analyzed separately. Enrollment is limited to residents of Southern Wisconsin.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
98
Inclusion Criteria
  • Pain from knee osteoarthritis that has impacted life for 3 months to 10 years
  • X-ray results indicating knee osteoarthritis
Exclusion Criteria
  • Knee osteoarthritis surgical candidate
  • History of total knee joint repair
  • Prior use of PrT
  • Prior fracture of the knee joint
  • Joint injection of steroids or other drugs within the past 3 months
  • Rheumatoid or inflammatory arthritis
  • Chronic use of narcotic medication
  • Other chronic pain diagnoses
  • diabetes mellitus
  • Body mass index (BMI) greater than 45
  • Unresolved litigation
  • Pregnancy
  • Co-morbidity that may interfere with the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
DextroseDextrose ProlotherapySubjects in Group 1 receive PrT with 15% and 25% dextrose solution, as it is generally practiced in the US today.
Normal salineSaline ProlotherapySubjects in Group 2 will receive the same treatment as Group 1, except that a 0.9% 'normal' saline solution with no known benefit will be used instead of dextrose.
ExerciseAt-home physical therapy exercise groupAt-home physical therapy exercises as a non-injection control
Primary Outcome Measures
NameTimeMethod
Quality of life, pain scores and disability at wks 0, 5, 9, 12, 24, 52Participants will be followed for one year.
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes include disease and general quality of life indicators (all subjects) and magnetic resonance image (in a subset of 37 subjects).Participants will be monitored for one year.

Trial Locations

Locations (2)

Northeast Family Medical Center

🇺🇸

Madison, Wisconsin, United States

University of Wisconsin General Clinical Research Center

🇺🇸

Madison, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath